These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32301996)

  • 41. Convection-Enhanced Delivery in Children: Techniques and Applications.
    Aquilina K; Chakrapani A; Carr L; Kurian MA; Hargrave D
    Adv Tech Stand Neurosurg; 2022; 45():199-228. PubMed ID: 35976451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue.
    Heravi Shargh V; Luckett J; Bouzinab K; Paisey S; Turyanska L; Singleton WGB; Lowis S; Gershkovich P; Bradshaw TD; Stevens MFG; Bienemann A; Coyle B
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35266-35280. PubMed ID: 34310112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model.
    Chevaleyre C; Kereselidze D; Caillé F; Tournier N; Olaciregui NG; Winkeler A; Declèves X; Jego B; Cisternino S; Auvity S; Truillet C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.
    Chittiboina P; Heiss JD; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2014 Mar; 13(3):276-82. PubMed ID: 24410126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.
    Katagi H; Takata N; Aoi Y; Zhang Y; Rendleman EJ; Blyth GT; Eckerdt FD; Tomita Y; Sasaki T; Saratsis AM; Kondo A; Goldman S; Becher OJ; Smith E; Zou L; Shilatifard A; Hashizume R
    Neuro Oncol; 2021 Aug; 23(8):1348-1359. PubMed ID: 33471107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
    Lobon-Iglesias MJ; Santa-Maria Lopez V; Puerta Roldan P; Candela-Cantó S; Ramos-Albiac M; Gomez-Chiari M; Puget S; Bolle S; Goumnerova L; Kieran MW; Cruz O; Grill J; Morales La Madrid A
    J Neurosurg Pediatr; 2018 Dec; 22(6):678-683. PubMed ID: 30192215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges.
    Himes BT; Zhang L; Daniels DJ
    Front Oncol; 2019; 9():31. PubMed ID: 30800634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.
    Lian X; Kats D; Rasmussen S; Martin LR; Karki A; Keller C; Berlow NE
    Acta Neuropathol Commun; 2021 May; 9(1):88. PubMed ID: 34001278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.
    Singh R; Zhou Z; Tisnado J; Haque S; Peck KK; Young RJ; Tsiouris AJ; Thakur SB; Souweidane MM
    J Neurosurg Pediatr; 2016 Nov; 18(5):565-572. PubMed ID: 27391980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas.
    Dalle Ore C; Coleman C; Gupta N; Mueller S
    Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
    Zhang L; Yu H; Xue Y; Liu Y
    Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Drug Imaging:
    Jansen MH; Veldhuijzen van Zanten SEM; van Vuurden DG; Huisman MC; Vugts DJ; Hoekstra OS; van Dongen GA; Kaspers GL
    J Nucl Med; 2017 May; 58(5):711-716. PubMed ID: 27765855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
    Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
    Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
    Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
    Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
    [No Abstract]   [Full Text] [Related]  

  • 56. Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
    Monje M; Cooney T; Glod J; Huang J; Peer CJ; Faury D; Baxter P; Kramer K; Lenzen A; Robison NJ; Kilburn L; Vinitsky A; Figg WD; Jabado N; Fouladi M; Fangusaro J; Onar-Thomas A; Dunkel IJ; Warren KE
    Neuro Oncol; 2023 Dec; 25(12):2262-2272. PubMed ID: 37526549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.
    Chang R; Tosi U; Voronina J; Adeuyan O; Wu LY; Schweitzer ME; Pisapia DJ; Becher OJ; Souweidane MM; Maachani UB
    Neurooncol Adv; 2019; 1(1):vdz004. PubMed ID: 32642647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies.
    Weisbrod LJ; Thiraviyam A; Vengoji R; Shonka N; Jain M; Ho W; Batra SK; Salehi A
    Cancer Lett; 2024 May; 590():216876. PubMed ID: 38609002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.
    Rechberger JS; Power BT; Power EA; Nesvick CL; Daniels DJ
    Expert Opin Ther Targets; 2023 Jan; 27(1):9-17. PubMed ID: 36744399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a patient-specific algorithm for predicting distribution for convection-enhanced drug delivery into the brainstem of patients with diffuse intrinsic pontine glioma.
    Wembacher-Schroeder E; Kerstein N; Bander ED; Pandit-Taskar N; Thomson R; Souweidane MM
    J Neurosurg Pediatr; 2021 Jul; 28(1):34-42. PubMed ID: 33990084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.